Skip to main content
logo
SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
13.34
+0.13 (0.98%)
At close: Aug 31, 2026, 4:00 PM EDT
13.27
-0.07 (-0.52%)
Pre-market: Sep 1, 2026, 4:21 AM EDT

SLS Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----17.6
Revenue Growth
-----86.84%300.00%
Gross Profit
----0.97.4
Operating Income
-33.12-27.17-31.51-37.87-31.95-19.59
Net Income
-32.46-26.86-30.88-37.34-41.3-20.7
Earnings Per Share
-0.21-0.25-0.50-1.34-2.13-1.34
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
138.3471.7913.892.5317.1321.36
Total Debt
0.74110.910.950.81
Net Cash (Debt)
137.6170.7912.891.6216.1820.55
Net Cash Growth
460.29%449.41%693.41%-89.96%-21.25%-40.12%
Net Cash Per Share
0.900.650.210.060.831.33

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-28.42-28.39-35.4-31.41-23.81-26.02
Capital Expenditures
------
Free Cash Flow
-28.42-28.39-35.4-31.41-23.81-26.02
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----90.00%97.37%
Operating Margin
-----3195.00%-257.82%
Pretax Margin
-----4130.10%-275.47%
Profit Margin
-----4130.10%-272.36%
FCF Margin
-----2380.90%-342.38%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----48.5911.56